Because the fetal endocrine pancreas already acquires an insulin response to fetal glycemia at 14–20 GW, fetal abdominal overgrowth risk appears early in pregnancy for women developing gestational glucose intolerance [32], especially for women with obesity and/or advanced maternal age. This evidence concerns the gene INS and Obesity.